Efficacy of lurasidone in schizophrenia: pooled analysis of the five PANSS factors in short-term trials

被引：0
|
作者：
Werner, P. [1 ]
Cucchiaro, J.
Silva, R.
Pikalov, A.
Mao, Y.
Loebel, A.
Marder, S. [2 ]
机构：
[1] Sunov Pharmaceut Inc, Med Affairs, Marlborough, MA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci, Los Angeles, CA 90095 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70526-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S341 / S341
页数：1
相关论文
共 50 条
  • [31] EFFICACY OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A POOLED ANALYSIS BASED ON A 5-FACTOR MODEL OF SCHIZOPHRENIA
    Loebel, Antony
    Cucchiaro, Josephine
    Silva, Robert
    Ogasa, Masaaki
    Severs, Joseph
    Marder, Stephen R.
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 267 - 267
  • [32] Efficacy and safety of lurasidone for schizophrenia: A systematic review and meta-analysis of eight short-term, randomized, double-blind, placebo-controlled clinical trials
    Gao, Shan
    Fan, Ling
    Yu, Zhigang
    Xie, Xingxing
    BIOMEDICAL REPORTS, 2024, 20 (06)
  • [33] META-ANALYSIS OF DRIVERS OF COST-EFFECTIVENESS FROM SHORT-TERM LURASIDONE CLINICAL TRIALS: EFFECT OF CHANGING DAILY DOSE ON PANSS TOTAL SCORE AND WEIGHT
    Rajagopalan, K.
    Trueman, D.
    Crowe, L.
    Pikalov, A.
    Hsu, J.
    Loebel, A.
    VALUE IN HEALTH, 2014, 17 (03) : A208 - A208
  • [34] Efficacy and safety of selegiline transdermal system for atypical depression: pooled analysis of short-term placebo-controlled trials
    Patkar, A. A.
    Jang, S.
    Portland, K.
    Jung, S.
    Pae, C.
    Nelson, J. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S257 - S258
  • [35] Effect of lurasidone on weight and metabolic parameters: a comprehensive analysis of short- and long-term trials in schizophrenia
    Pikalov, A.
    Cucchiaro, J.
    Ogasa, M.
    Silva, R.
    Hsu, J.
    Xu, J.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S339 - S340
  • [36] The Acute Efficacy of Aripiprazole Across the Symptom Spectrum of Schizophrenia: A Pooled Post Hoc Analysis From 5 Short-Term Studies
    Janicak, Philip G.
    Glick, Ira D.
    Marder, Stephen R.
    Crandall, David T.
    McQuade, Robert D.
    Marcus, Ronald N.
    Eudicone, James M.
    Assuncao-Talbott, Sheila
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (01) : 25 - 35
  • [37] EFFECT OF LURASIDONE ON WEIGHT AND METABOLIC PARAMETERS. A COMPREHENSIVE ANALYSIS OF SHORT- AND LONG-TERM TRIALS IN SCHIZOPHRENIA
    Pikalov, A.
    Cucchiaro, J.
    Ogasa, M.
    Silva, R.
    Hsu, J.
    Xu, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [38] Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials
    Citrome, Leslie
    Meng, Xiangyi
    Hochfeld, Marla
    Stahl, Stephen M.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2012, 27 (01) : 24 - 32
  • [39] Oral ziprasidone in the treatment of schizophrenia: A review of short-term trials
    Kane, JM
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 : 19 - 25
  • [40] SHORT-TERM AND LONG-TERM EFFICACY OF BREXPIPRAZOLE IN ADULTS WITH SCHIZOPHRENIA: EFFECT ACROSS MARDER FACTORS
    Weiss, Catherine
    Forbes, Andy
    Hobart, Mary
    Pfister, Stephanie
    Ouyang, John
    Weiller, Emmanuelle
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S154 - S154
12345